Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 11:23 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.
View All Commentary (ENZN)
Recs
hennessy7 (< 20) Submitted: 5/26/08 9:12 AM : Start Price: $8.85 ENZN Score: 1.00
I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.